Potassium chloride

Verde Announces Q1 2024 Results

Retrieved on: 
星期三, 五月 15, 2024

SINGAPORE, May 14, 2024 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the period ended March 31, 2024 (“Q1 2024”).

Key Points: 
  • Sales in Q1 2024 were 85,000 tonnes, compared to 108,000 tonnes in Q1 2023 and 16,558 tonnes in Q1 2021.
  • Revenue in Q1 2024 was $5.1 million, compared to $11.1 million in Q1 2023 and $0.8 million in Q1 2021.
  • EBITDA before non-cash events was -$0.7 million in Q1 2024, compared to $2.0 million in Q1 2023 and a -$0.9 million in Q1 2021.
  • Net loss in Q1 2024 was $4.8 million, compared to a $0.1 million loss in Q1 2023 and a $1.8 million loss in Q1 2021.

Verde Announces Q4 and FY 2023 Results

Retrieved on: 
星期四, 三月 28, 2024

SINGAPORE, March 28, 2024 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the full year ended December 31, 2023 (“FY 2023”) and the fourth quarter 2023 (“Q4 2023”), as audited by Ernst & Young (“EY”). The FY 2023 audited results were consistent with the interim results announced by the Company on January 26, 2024:

Key Points: 
  • Verde's revenue amounted to $37.9 million in FY 2023, a 53% decrease compared to the previous year, when potash prices reached record levels.
  • The Company reported a net loss of $6.0 million in FY 2023, compared to a net profit of $17.8 million in FY 2022.
  • Canadian dollar devaluated by 7% versus Brazilian Real in FY 2023 compared to FY 2022.
  • The Company will host a conference call on Tuesday, April 02, 2024, at 10:00 am Eastern Time, to discuss Q4 and FY 2023 results and provide an update.

Automate Analysis and Enhance Lab Safety with New NexaFlo™ Segmented Flow Analyzer

Retrieved on: 
星期三, 四月 3, 2024

, April 3, 2024 /PRNewswire/ -- Speed up analytical processes while also enhancing lab safety with a new segmented flow analyzer from KPM Analytics.

Key Points: 
  • , April 3, 2024 /PRNewswire/ -- Speed up analytical processes while also enhancing lab safety with a new segmented flow analyzer from KPM Analytics.
  • NexaFlo™ is the fourth generation of segmented flow analyzers from KPM, which has supplied thousands of consoles for laboratories across the globe.
  • One key feature of the NexaFlo™ analyzer is that it was designed to directly address lab safety.
  • For more information about NexaFlo™ segmented flow analyzers, visit the KPM Analytics product page for this new addition to our lineup: www.kpmanalytics.com/products/chemical-clinical/nexaflo-segmented-flow-a... .

Automate Analysis and Enhance Lab Safety with New NexaFlo™ Segmented Flow Analyzer

Retrieved on: 
星期三, 四月 3, 2024

WESTBOROUGH, Mass., April 3, 2024 /PRNewswire/ -- Speed up analytical processes while also enhancing lab safety with a new segmented flow analyzer from KPM Analytics.

Key Points: 
  • WESTBOROUGH, Mass., April 3, 2024 /PRNewswire/ -- Speed up analytical processes while also enhancing lab safety with a new segmented flow analyzer from KPM Analytics.
  • NexaFlo™ is the fourth generation of segmented flow analyzers from KPM, which has supplied thousands of consoles for laboratories across the globe.
  • One key feature of the NexaFlo™ analyzer is that it was designed to directly address lab safety.
  • For more information about NexaFlo™ segmented flow analyzers, visit the KPM Analytics product page for this new addition to our lineup: www.kpmanalytics.com/products/chemical-clinical/nexaflo-segmented-flow-a... .

Intrepid Announces Fourth Quarter and Full-Year 2023 Results

Retrieved on: 
星期三, 三月 6, 2024

Denver, CO, March 06, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (NYSE:IPI) ("Intrepid", the "Company", "we", "us" and "our") today reports its financial results for the fourth quarter and full-year of 2023.

Key Points: 
  • Denver, CO, March 06, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (NYSE:IPI) ("Intrepid", the "Company", "we", "us" and "our") today reports its financial results for the fourth quarter and full-year of 2023.
  • Included in the GAAP net loss figures are non-cash impairment charges of $42.8 million in the fourth quarter of 2023 and $43.3 million for the full-year 2023.
  • Adjusted EBITDA(1) of $7.1 million for the fourth quarter, bringing our full-year 2023 adjusted EBITDA to $41.6 million.
  • Intrepid generated fourth quarter and full-year 2023 sales of approximately $56.7 million and $279.1 million, respectively, which compares to fourth quarter and full-year 2022 sales of approximately $66.7 million and $337.6 million, respectively.

FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin

Retrieved on: 
星期四, 二月 1, 2024

PEDMARK is the first and only FDA approved therapy indicated to reduce the risk of ototoxicity (e.g., permanent hearing loss) associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.

Key Points: 
  • PEDMARK is the first and only FDA approved therapy indicated to reduce the risk of ototoxicity (e.g., permanent hearing loss) associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.
  • The FDA reminded health care providers that as stated in PEDMARK’s prescribing information , PEDMARK is not substitutable with other sodium thiosulfate products.
  • Sodium nitrite is co-packaged with sodium thiosulfate as a separate vial in some products; it is not present in PEDMARK.
  • The FDA encourages those with any questions to contact [email protected].

This salt alternative could help reduce blood pressure. So why are so few people using it?

Retrieved on: 
星期二, 一月 30, 2024

Excess salt (sodium) increases the risk of high blood pressure so everyone with hypertension is advised to reduce salt in their diet.

Key Points: 
  • Excess salt (sodium) increases the risk of high blood pressure so everyone with hypertension is advised to reduce salt in their diet.
  • It can be used just like regular salt and most people don’t notice any important difference in taste.
  • Switching to potassium-enriched salt is feasible in a way that cutting salt intake is not.

What is potassium-enriched salt?

  • Potassium-enriched salts replace some of the sodium chloride that makes up regular salt with potassium chloride.
  • They’re also called low-sodium salt, potassium salt, heart salt, mineral salt, or sodium-reduced salt.

What is the evidence?


We have strong evidence from a randomised trial of 20,995 people that switching to potassium-enriched salt lowers blood pressure and reduces the risks of stroke, heart attacks and early death. The participants had a history of stroke or were 60 years of age or older and had high blood pressure.
An overview of 21 other studies suggests much of the world’s population could benefit from potassium-enriched salt. The World Health Organisation’s 2023 global report on hypertension highlighted potassium-enriched salt as an “affordable strategy” to reduce blood pressure and prevent cardiovascular events such as strokes.

What should clinical guidelines say?

  • We teamed up with researchers from the United States, Australia, Japan, South Africa and India to review 32 clinical guidelines for managing high blood pressure across the world.
  • While many guidelines recommend increasing dietary potassium intake, and all refer to reducing sodium intake, only two guidelines – the Chinese and European – recommend using potassium-enriched salt.

Why do so few people use it?

  • Few people know a simple switch to potassium-enriched salt can help lower blood pressure and reduce the risk of a stroke and heart disease.
  • Several Australian retailers stock potassium-enriched salt but there is usually only one brand available, and it is often on the bottom shelf or in a special food aisle.


A 2021 review found potassium-enriched salts were marketed in only 47 countries and those were mostly high-income countries. Prices ranged from the same as regular salt to almost 15 times greater. Even though generally more expensive, potassium-enriched salt has the potential to be highly cost effective for disease prevention.

Preventing harm

  • People with serious kidney disease are already advised to avoid regular salt and to avoid foods high in potassium.
  • No harm from potassium-enriched salt has been recorded in any trial done to date, but all studies were done in a clinical setting with specific guidance for people with kidney disease.
  • In some countries, potassium-enriched salt is recommended to the entire community because the potential benefits are so large.

What will happen next?

  • We are working with the taskforce to update Australian hypertension management guidelines, and to promote the new guidelines to health professionals.
  • The next switch to iodised and potassium-enriched salt offers at least the same potential for global health gains.
  • But we need to make it happen in a fraction of the time.
  • Alta Schutte receives funding from the National Health and Medical Research Council of Australia, the Medical Research Future Fund, and NSW Health.
  • She is Company Secretary of the Australian Cardiovascular Alliance, Board Member of Hypertension Australia, and Co-Chair of the National Hypertension Taskforce of Australia.

Cloud Seeding Market to surpass $194.9 million by 2031 Globally, at a CAGR of 5.8%, says Coherent Market Insights

Retrieved on: 
星期三, 一月 17, 2024

Growing Adoption of Hygroscopic Seeding Agents:

Key Points: 
  • Growing Adoption of Hygroscopic Seeding Agents:
    One of the key trends in the cloud seeding market is the increasing adoption of hygroscopic seeding agents.
  • Focus on Western Countries for Cloud Seeding Operations:
    Another trend observed in the cloud seeding market is the increasing focus on Western countries for cloud seeding operations.
  • By Method of Cloud Seeding: Ground-based Cloud Seeding (dominating), Airborne Cloud Seeding, Remote Cloud Seeding, Hygroscopic Cloud Seeding, Ice Nucleation Cloud Seeding, Silver Iodide Cloud Seeding, Others
    Ground-based cloud seeding is expected to be the dominating method of cloud seeding.
  • Airborne cloud seeding, which involves the use of aircraft for cloud seeding, and remote cloud seeding using drones or unmanned aircraft, also present potential market opportunities.

Cloud Seeding Market to surpass $194.9 million by 2031 Globally, at a CAGR of 5.8%, says Coherent Market Insights

Retrieved on: 
星期三, 一月 17, 2024

Growing Adoption of Hygroscopic Seeding Agents:

Key Points: 
  • Growing Adoption of Hygroscopic Seeding Agents:
    One of the key trends in the cloud seeding market is the increasing adoption of hygroscopic seeding agents.
  • Focus on Western Countries for Cloud Seeding Operations:
    Another trend observed in the cloud seeding market is the increasing focus on Western countries for cloud seeding operations.
  • By Method of Cloud Seeding: Ground-based Cloud Seeding (dominating), Airborne Cloud Seeding, Remote Cloud Seeding, Hygroscopic Cloud Seeding, Ice Nucleation Cloud Seeding, Silver Iodide Cloud Seeding, Others
    Ground-based cloud seeding is expected to be the dominating method of cloud seeding.
  • Airborne cloud seeding, which involves the use of aircraft for cloud seeding, and remote cloud seeding using drones or unmanned aircraft, also present potential market opportunities.

Lithium Argentina Announces 2023 Production Results for Caucharí-Olaroz

Retrieved on: 
星期三, 一月 10, 2024

VANCOUVER, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) (“Lithium Argentina” or the “Company”) today announced preliminary 2023 operational results for the Caucharí-Olaroz lithium brine operation (“Caucharí-Olaroz” or the “Project”) in Jujuy, Argentina.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) (“Lithium Argentina” or the “Company”) today announced preliminary 2023 operational results for the Caucharí-Olaroz lithium brine operation (“Caucharí-Olaroz” or the “Project”) in Jujuy, Argentina.
  • 2023 production surpassed guidance reaching approximately 6,000 tonnes of lithium carbonate.
  • Lithium Argentina to report year-end financial results on March 21, 2024 after market close.
  • Lithium Argentina plans release its fourth quarter and full year 2023 financial results, including an update on production guidance for 2024, after market hours on, March 21, 2024.